Cyclacel Pharmaceuticals ... (CYCC)
0.33
-0.00 (-0.45%)
At close: Mar 03, 2025, 12:27 PM
Cyclacel Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
11
Upside
3254.68
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Jonathan Aschoff (0)
| Roth MKM | Buy | Maintains | 21 11 | May 3, 2024 |
Kemp Dolliver (0)
| Brookline Capital | Hold | Downgrades | n/a | Dec 19, 2023 |
Jonathan Aschoff (0)
| Roth MKM | Strong Buy | Maintains | 16 21 | Dec 19, 2023 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.